Zobrazeno 1 - 10
of 152
pro vyhledávání: '"Nissim, Haim"'
Autor:
Rahamim Ben-Yosef, Orit Kaidar-Person, Nissim Haim, Katerina Shulman, Samar Musallam, Ron Epelbaum
Publikováno v:
American Journal of Clinical Oncology. 43:861-864
OBJECTIVES Oncological treatments of older patients have many unresolved questions mainly because of the fact that these patients were not eligible to be included in most clinical trials. The aim of this study was to evaluate the treatment approach t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5bb4a58651e9d17338baf4a9350dd2d
https://doi.org/10.1097/coc.0000000000000767
https://doi.org/10.1097/coc.0000000000000767
Autor:
Yona Nadir, Nissim Haim, Anat Keren-Politansky, Corinne Maurice-Dror, Michael Litvak, Shanny Ackerman
Publikováno v:
Journal of Thrombosis and Thrombolysis. 50:112-122
Hospitalized cancer patients are at increased risk of thrombosis and prophylaxis with heparin is recommended. Heparanase is a protein capable of degrading heparan sulfate (HS) chains. The first objective of the study was to examine the effects of wei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11ad61eae8cf0d3672086ecddd9debe0
https://doi.org/10.1007/s11239-020-02128-1
https://doi.org/10.1007/s11239-020-02128-1
Autor:
Tareq Artul, Nissim Haim, Michael Litvak, Ali Jabareen, Suheir Assady, Nethanel Horowitz, Razan Sakran, Edna Efrati, Gai Milo, Daniel Kurnik, Shimrit Ringelstein-Harlev
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 28(2)
Introduction Acute kidney injury (AKI) after high dose methotrexate (HD-MTX) is associated with delayed MTX-excretion and life-threatening toxicity. Glucapridase, the recommended therapy, is expensive and not always available. Case series We describe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9edaedb7e5c25cd99cd9dcc62ff8d05b
https://pubmed.ncbi.nlm.nih.gov/34668443
https://pubmed.ncbi.nlm.nih.gov/34668443
Publikováno v:
Case Reports in Oncological Medicine, Vol 2015 (2015)
Oxaliplatin is a common chemotherapy drug, used mainly for colon and gastric cancer. Most common side effects are peripheral sensory neuropathy, hematological toxicity, and allergic reactions. A less common side effect is pulmonary toxicity, characte
Externí odkaz:
https://doaj.org/article/4b3142004aea4dc699a5995bc942c8ad
Publikováno v:
Cancer chemotherapy and pharmacology. 84(4)
Olaratumab (O) is a monoclonal antibody that specifically binds PDGFRα. The addition of O to doxorubicin (D) has been approved by the regulatory authorities for metastatic soft tissue sarcoma (MSTS). Since the combination of D + ifosfamide (I) is co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9749e77d9869475653b34099abd8723
https://pubmed.ncbi.nlm.nih.gov/31410509
https://pubmed.ncbi.nlm.nih.gov/31410509
Publikováno v:
Journal of Clinical Oncology. 37:e13581-e13581
e13581 Background: Brain metastases are estimated to occur in approximately 30% of patients with metastatic non-small cell lung cancer (NSCLC). Patients with brain metastases experience significant morbidity, often with neurological dysfunction and c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4548ed42b26d12383c22ff10a12bf99
https://doi.org/10.1200/jco.2019.37.15_suppl.e13581
https://doi.org/10.1200/jco.2019.37.15_suppl.e13581
Publikováno v:
Clinical Colorectal Cancer. 14:e49-e51
Irinotecan is widely used in the treatment of gastrointestinal malignancies. Generalized hypersensitivity reactions (HSRs) to irinotecan have been described previously, but desensitization has not been reported in the English literature. The current
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd5a04465529551c74bdc28aca3a8bdb
https://doi.org/10.1016/j.clcc.2015.05.003
https://doi.org/10.1016/j.clcc.2015.05.003
Publikováno v:
Japanese Journal of Clinical Oncology. 45:881-883
Vemurafenib and dabrafenib are both orally bioavailable small molecule agents that block mitogen activated protein kinase signalling in patients with melanoma and BRAF(V600E) mutation. Generalized hypersensitivity reactions to vemurafenib or dabrafen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8de7ca5cf065c8c82ea5936442c320b8
https://doi.org/10.1093/jjco/hyv086
https://doi.org/10.1093/jjco/hyv086
Publikováno v:
European Journal of Cancer. 49:1058-1064
Introduction Mistletoe preparations, such as iscador, are common complementary medications. This randomised phase II study of iscador combined with carboplatin-containing regimens was conducted in chemotherapy-naive advanced non-small-cell lung cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06e86f13b600d55184576d0cbb51f72d
https://doi.org/10.1016/j.ejca.2012.11.007
https://doi.org/10.1016/j.ejca.2012.11.007
Autor:
Gil Bar-Sela, Roxylana Abdah-Bortnyak, Nissim Haim, Mira Wollner, Zvi Bernstein, Katerina Shulman
Publikováno v:
Oncology Letters. 3:1154-1158
The prognosis following surgical treatment of gastric carcinoma (GC) or gastroesophageal junction (GEJ) adenocarcinoma remains poor. Although adjuvant chemo-radiotherapy with 5-fluorouracil has been shown to be beneficial, a high rate of distant fail
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::348af9fd3649ed20a0920dfee0e05bc5
https://doi.org/10.3892/ol.2012.617
https://doi.org/10.3892/ol.2012.617